首页> 美国卫生研究院文献>Cold Spring Harbor Molecular Case Studies >Lynch syndrome–associated ultra-hypermutated pediatric glioblastoma mimicking a constitutional mismatch repair deficiency syndrome
【2h】

Lynch syndrome–associated ultra-hypermutated pediatric glioblastoma mimicking a constitutional mismatch repair deficiency syndrome

机译:Lynch综合征相关的超小儿成胶质细胞瘤模仿体质不匹配修复缺陷综合征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pediatric glioblastoma multiforme (GBM) has a poor prognosis as a result of recurrence after treatment of surgery and radiochemotherapy. A small subset of pediatric GBMs presenting with an ultra-high tumor mutational burden (TMB) may be sensitive to immune checkpoint inhibition. Here we report a 16-yr-old male with an ultra-hypermutated GBM. After incomplete surgical resection, molecular analysis of the tumor identified unusually high numbers of mutations and intratumor heterogeneity by a hotspot next-generation sequencing (NGS) panel. Further comprehensive molecular profiling identified a TMB of 343 mutations/Mb. An ultra-hypermutation genotype in pediatric GBMs is suggestive of a constitutive mismatch repair deficiency syndrome (CMMRD), which often acquires additional somatic driver mutations in replicating DNA polymerase genes. Tumor sequencing identified two nonsense variants, a hotspot mutation and a mutational signature supportive of a germline MMR deficiency with a somatic mutation. However, constitutional testing identified only one nonsense variant consistent with a Lynch syndrome diagnosis. This case represents the first confirmed Lynch syndrome case mimicking CMMRD by manifesting as an ultra-hypermutated pediatric GBM, following somatic mutations in and . These findings permitted the patient's enrollment in an anti-PD-1 clinical trial for children with ultra-hypermutated GBM. Immunotherapy response has resulted in the patient's stable condition for over more than 1 year postdiagnosis.
机译:小儿多形性胶质母细胞瘤(GBM)由于手术治疗和放化疗后复发,预后较差。表现出超高肿瘤突变负担(TMB)的一小部分儿科GBM可能对免疫检查点抑制敏感。在这里,我们报告了16岁的男性,其GBM超高变。手术切除不完全后,通过热点新一代测序(NGS)小组对肿瘤进行分子分析,发现异常高的突变数和肿瘤内异质性。进一步的综合分子谱分析确定了343个突变/ Mb的TMB。儿科GBMs的超高变基因型提示组成性失配修复缺陷综合症(CMMRD),该病通常在复制DNA聚合酶基因时获得额外的体细胞驱动突变。肿瘤测序鉴定了两个无意义的变异,一个热点突变和一个支持体细胞突变的种系MMR缺陷的突变特征。但是,体质测试仅发现了一种与Lynch综合征诊断相符的废话。该病例代表了首例经证实的Lynch综合征,模仿CMMRD,其表现为在和中发生体细胞突变后的超高位儿科GBM。这些发现允许患者参与针对超高变GBM儿童的抗PD-1临床试验。免疫治疗反应已使患者在诊断后超过1年保持稳定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号